Ontology highlight
ABSTRACT:
SUBMITTER: Testa JR
PROVIDER: S-EPMC5889618 | biostudies-literature | 2013
REPOSITORIES: biostudies-literature
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 20130101
An understanding of the genetic causes and molecular pathways of hereditary cancer syndromes has historically informed our knowledge and treatment of all types of cancers. For this review, we focus on three rare syndromes and their associated genetic mutations including BAP1, TP53, and SDHx (SDHA, SDHB, SDHC, SDHD, SDHAF2). BAP1 encodes an enzyme that catalyzes the removal of ubiquitin from protein substrates, and germline mutations of BAP1 cause a novel cancer syndrome characterized by high inc ...[more]